BioTE Appears in 1.9% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.

Mark HuntleyBy Mark HuntleyFounder and CEO
9 minutes read

Key Takeaways

  • BioTE appeared in 7 of 363 benchmark AI answers, but none of those mentions led to a recommendation.
  • The article treats November 2026 as a baseline, not a month-over-month trend, because earlier samples used a narrower question set.
  • No conflicting claims were recorded in the captured answers, so the first step is to verify questions, pages and sources before proposing edits.
  • The strongest content opportunities are side effects, competitor comparisons and local buyer questions, where BioTE is mentioned but never endorsed.

Answer Capsule

In November 2026, BioTE appeared in 7 of 363 AI answers included in the TRT Clinics benchmark (1.93%). It received 0 recommendations (0.00%), with 0 Top 3 placements and 0 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.

Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.

Current AI visibility

Questions This Section Answers

  • How do BioTE mentions, recommendations and placements compare with its TRT Clinics peers?

BioTE recorded 7 mentions (1.93%) and 0 recommendations (0.00%) across 363 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 4 neutral and 3 negative.

Rank

Company

Mentions

Mention rate

Recommendations

Recommendation rate

Top 3

Top 3 rate

#1

#1 rate

1

Hone Health

271

74.66%

146

40.22%

123

33.88%

64

17.63%

2

Defy Medical

113

31.13%

81

22.31%

64

17.63%

12

3.31%

3

Maximus

116

31.96%

64

17.63%

49

13.50%

18

4.96%

4

Marek Health

78

21.49%

39

10.74%

30

8.26%

7

1.93%

5

Henry Meds

86

23.69%

35

9.64%

28

7.71%

6

1.65%

6

Fountain TRT

57

15.70%

25

6.89%

13

3.58%

1

0.28%

7

Renew Vitality

6

1.65%

5

1.38%

5

1.38%

0

0.00%

8

Low T Center

11

3.03%

4

1.10%

2

0.55%

1

0.28%

9

BioTE

7

1.93%

0

0.00%

0

0.00%

0

0.00%

9

Craft Concierge

0

0.00%

0

0.00%

0

0.00%

0

0.00%

BioTE appears in a small slice of the answers studied, and none of those appearances carried an endorsement. That gap matters more than the mention count: buyers asking for a clinic recommendation are not being pointed to BioTE at all. The neutral and negative framing around its mentions suggests the answers describe the therapy without advocating it.

For the client, the practical starting point is not chasing a target rate but understanding which questions produce mentions and why those mentions stop short of endorsement. A visibility comparison against the clinics that do earn recommendations would show where BioTE is discussed but not chosen, which is the more useful signal for planning.

What changed since last month

Questions This Section Answers

  • How did BioTE counts and coverage differ across the available monthly snapshots?

Metric

Nov 2026

Mentions

7 / 363 (1.93%)

Recommendations

0 / 363 (0.00%)

Top 3 recommendations

0 / 363 (0.00%)

#1 recommendations

0 / 363 (0.00%)

Only months with verified results are shown. Monthly sample coverage is listed in Methodology.

This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.

This edition is the first broad baseline, so the figures describe one selected sample rather than a movement from earlier months. Earlier editions asked a narrower set of questions, which makes direct comparison unreliable. The observed totals should be read as a starting reference point.

That means the client should treat this month as the anchor for future comparison, not as evidence of decline or improvement. Future editions using the same screening scope will be the first genuinely comparable read, and the agency should keep the baseline scorecard stable so those comparisons stay meaningful.

AI recommendation trend

Observed recommendation rate (%), Nov 2026

  • BioTEno change
    Nov 20260.00%

Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.

/ Take the next step

Want to Understand Your AI Citation Footprint?

We start every engagement with a full audit of how AI systems reference your brand today.

Measurable, Repeatable Programme

Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge

Citation Architecture Review

Identify which high-authority community sources are and aren't working in your favour across AI platforms.

AI Visibility Audit

Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.

Step 1. Measure

Questions This Section Answers

  • What should the agency measure and verify first for BioTE?

AI answers contained 0 conflicting claims about BioTE: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No conflicting claims about BioTE were recorded in the captured answers, so there is nothing yet to rate for urgency. That is a clean starting position, but it also means the fact-check list has to be built from the questions and pages where BioTE actually appears rather than from flagged disputes.

A visibility comparison alongside a scoped list of claims worth verifying would let the client see where answers describe the therapy and decide which statements deserve a primary-source check. The agency would propose assembling that list with an owner and evidence requirement for each item, without treating any AI statement as established fact.

Step 2. Make the website consistent

Questions This Section Answers

  • Which recorded claim differences about BioTE should be verified before proposed page edits?

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis, so there are no disputed topics to brief against yet. The agency would not draft correction-oriented page briefs on an empty record; instead it would first confirm how BioTE is described on its own site and whether those descriptions match approved company facts.

Where a question later produces an apparent conflict, the first step is to resolve the entity, date and source before deciding whether a page change is warranted. Different dates can explain an apparent conflict, so conditional briefs should wait for that verification rather than assume an error.

Step 3. Align the external narrative

Questions This Section Answers

  • Which cited third-party pages are relevant to fact review for BioTE?

Cited page selected for review

Citation appearances in all captured answers

Answers mentioning the company

Conflicting claims linked to this page

https://remedytupelo.com/how-safe-is-biote-hormone-therapy/

2

2

0

https://essenzahealth.org/what-to-expect-with-biote-treatment-short-and-long-term/

1

1

0

https://evexias.com/founder-of-biote-medical-issues-apology-to-evexias-founder/

1

1

0

https://familymedicineinstitute.com/understanding-the-risks-of-biote-hormone-replacement-therapy/

1

1

0

https://gracefamilyheath.com/post/what-side-effects-should-i-know-about-for-biote-hormone-replacement

1

1

0

https://kudocarecenter.com/medical-services/biote/

1

1

0

These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.

The cited pages selected for review cluster around safety, side effects and what to expect from treatment, with one page touching on the company's history. None of them is linked to a recorded conflicting claim, so there is no correction case to pursue on this evidence. Citation here shows the pages appeared in answers, not that they shaped them.

The agency would propose reviewing each page's current content against primary sources before making any request, and would approach publishers only with evidence-backed, specific points. Requests should be framed as clarification, with no assumption of publisher control or error, and responses recorded separately from confirmed edits.

Step 4. Optimize priority company pages

Questions This Section Answers

  • Which observed BioTE website pages should receive review briefs?

Company website page

Citation appearances in all captured answers

Benchmark answers citing the page

Recommending answers citing the page

https://biote.com/

1

1

0

The company's website was cited 1 times across 1 distinct page addresses; the table shows 1 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.

Only the main company site was cited, and it appeared in benchmark answers without accompanying recommendations. That pattern suggests the site is being read as a source of information rather than as a reason to recommend BioTE. A single cited page is a thin base for judging the site's role.

The agency would propose a page brief built on approved facts and the questions buyers actually ask, checking existing coverage before suggesting anything new. The brief should separate what the page needs to state clearly from what the client still has to verify internally.

Step 5. Publish around buyer questions

Questions This Section Answers

  • Which observed buyer questions support content briefs for BioTE?

Question observed in the research

Benchmark answers to this question

Company mentions

Company recommendations

Are there bad side effects to BioTE?

3

3

0

Is EvexiPEL better than Biote?

1

1

0

What's the best TRT on the market?

2

1

0

hormone replacement therapy birmingham al

1

1

0

trt san diego

1

1

0

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

The recorded questions centre on side effects, a competitor comparison, a general market question and two local searches. BioTE was mentioned in answers to each but never recommended, which points to content that informs without giving a reason to choose the clinic. These are answer observations, not search volume or proof of missing pages.

The agency would propose buyer-question briefs for the side-effect and comparison topics first, since those are where a considered, evidence-based answer could matter most. Each brief should check existing coverage before proposing a new page, and local queries should be handled only once the client confirms which locations it actually serves.

Our 90-day action plan

Questions This Section Answers

  • How should the agency sequence the proposed BioTE work and judge completion?

Period

Deliverable

Completion criterion

Days 1–30

Baseline scorecard, scoped fact-review register and page/source shortlist

Each record has an owner, evidence requirement and review status

Days 31–60

Approved page briefs and justified publisher requests

Separate confirmed edits, no-change decisions, requests and responses

Days 61–90

Buyer-content briefs and a fresh scorecard

Record work completed separately from measured answer outcomes and comparability limits

The first month establishes the baseline scorecard, a scoped fact-review list and a shortlist of pages and sources, each with an owner and review status. The second month turns verified material into approved page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses logged separately.

The third month adds buyer-content briefs and a fresh scorecard. Delivered work will be recorded apart from measured answer outcomes, because completed briefs and requests do not by themselves change how AI answers describe or recommend BioTE.

Methodology

Questions This Section Answers

  • How are BioTE answer metrics and citation populations defined?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 363 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5316 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

Reporting month

Answers included

AI services covered

Services

Nov 2026

363

6

ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity

Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.

Future editions using the same screening scope can be compared against this baseline.

The answers were collected for this reporting month, though exact collection dates are unverified. A company counts as recommended only when an answer endorses it with positive wording, and top placements sit inside those recommendations rather than adding to them. Answers can cover several companies, so counts are not additive.

Citation appearances describe where pages were referenced, not what those pages currently say or whether they influenced an answer. Page contents and disputed claims still need independent verification, and this edition's broader scope makes it a baseline rather than a trend.

Our first three priorities

First, build the baseline scorecard and a scoped fact-review list so the client can see where BioTE is discussed without being endorsed. Second, verify the cited safety and side-effect pages against primary sources before any publisher contact, keeping ambiguous matches out of the queue. Third, prepare buyer-question briefs for the side-effect and comparison topics, checking existing coverage first.

Each step depends on the client confirming approved facts and service locations. The agency would treat these as proposed work with named owners, and would report completed briefs and requests separately from any later change in how answers describe BioTE.

This report supports CiteWorks Studio's examination of how AI search is recommending TRT Clinics. For more detail, you can also read TRT Clinics: AI Visibility Discovery Index.

/ Learn More

Understanding AI search visibility.

AI search experiences create answers by pulling information from many places online and summarizing it into a single response.

What Is AI Citation Intelligence?
AI citation intelligence is the process of measuring where AI platforms source their information and how frequently a brand is mentioned or referenced in AI-generated responses. Because LLMs synthesize across multiple sources, the sites and brands that appear repeatedly tend to influence how a topic or company is framed. This practice focuses on identifying which sources shape AI outputs and tracking brand visibility across different AI systems.
What Is Citation Architecture?
Citation architecture describes the set of sources that consistently inform how AI systems talk about a brand, product, or topic. LLMs draw from websites, articles, forums, and public discussion, and the sources they rely on most often become the backbone of their answers. Building strong citation architecture means ensuring that accurate, credible, high authority sources are the ones most likely to shape the way AI tools summarize and recommend a brand.
What Is Generative Engine Optimization?
Generative engine optimization (GEO) is the practice of improving the chances that AI systems use and cite your brand or content when generating answers. While traditional SEO is centered on ranking pages in search results, GEO focuses on how LLMs retrieve, interpret, and combine information when responding to a question. The objective is to strengthen the content and sources AI systems rely on, so your brand is treated as a trusted reference in AI responses.
What Is AI Share of Voice?
AI share of voice tracks how often a brand appears in AI-generated answers compared with competitors in the same category. It reflects visibility across AI platforms such as ChatGPT, Gemini, Claude, and Perplexity. Monitoring AI share of voice helps organizations see whether AI systems consistently include and recommend their brand for key queries or whether competitor brands are showing up more often.

About The Author

Mark Huntley

Mark Huntley

Founder and CEO

Mark Huntley, J.D. is founder of CiteWorks Studio, a strategic advisory focused on visibility, authority, and recommendation presence in AI-shaped search environments. His work centers on embedding-level GEO, vector optimization, and cosine gap engineering — helping brands align their digital presence with the retrieval systems that increasingly shape discovery, interpretation, and choice.

VIEW ALL CASE STUDIESREQUEST AN AI VISIBILITY AUDIT